Skip to content
Link copied!

盛弘醫藥股份有限公司 2025 Sustainability Report

  • Reporting Year:2025

  • Disclosure Period:2025/01/01 ~ 2025/12/31

  • Industry:生技醫療業

  • Verification Standards:GRI準則

Report summary

  • This page summarizes the 2025 sustainability report and ESG report PDF source for 盛弘醫藥股份有限公司 (8403).
  • The reporting period is 2025/01/01 to 2025/12/31, in the 生技醫療業 industry.
  • third-party verification or assurance body information is not currently provided; this can be used to review report verification, assurance, and disclosure standards.
  • Compare public disclosure approaches across prior-year and peer reports. Your company’s actual disclosures must still be based on its own data and supporting evidence.

Report details

Company
盛弘醫藥股份有限公司(8403)
Reporting Year
2025
Disclosure Period
2025/01/01 to 2025/12/31
Industry
生技醫療業
Third-party information
third-party verification or assurance body information is not currently provided
PDF source
The original ESG report PDF can be downloaded or opened from this page

2025 ESG Metrics and Industry Comparison

Greenhouse Gas Emissions

Scope 1 Emissions (Tons CO2e)
311
Reporting Boundary:已完成合併財務報表之母子公司
Verification:是
Scope 2 Emissions (Tons CO2e)
2,994
Reporting Boundary:已完成合併財務報表之母子公司
Verification:是
Scope 3 Emissions (Tons CO2e)
3,062
Reporting Boundary:已完成合併財務報表之母子公司
Verification:是

Energy Management

Renewable Energy Share
Not disclosed
Reporting Boundary:Not disclosed
Verification:Not disclosed

Water Management

Water Use (Metric Tons)
16,126
Reporting Boundary:桃園市桃園區經國路168號23F、22F、B2F 臺北市大安區基隆路二段172-1號2樓 桃園市桃園區民生路107號1F-3 F、5-18 F、B1F-B3F
Verification:Not disclosed

Board of Directors

Board Seats (Including Independent Directors)
11
Independent Director Seats
4
Female Director Ratio
27.3%
Ranked 38 among 96 companies in the same industry (percentile 61).
Board Meeting Attendance Rate
95.5%
Ranked 62 among 96 companies in the same industry (percentile 35).
Independent Director Ratio
36.4%
Ranked 67 among 96 companies in the same industry (percentile 27).

Source: Taiwan Stock Exchange / Taipei Exchange, Corporate ESG Disclosure Summary (2025), under the Open Government Data License, version 1.0. Open Government Data License, Version 1.0

How to use this report

  • Compare how 盛弘醫藥股份有限公司 structured 生技醫療業 sustainability report chapters and material topics in 2025.
  • Confirm the reporting period, third-party verification or assurance information, and downloadable ESG report PDF source.
  • Mark public disclosures and original page numbers that can be referenced as research materials for planning chapters and indicators for your own company.

Historical Reports

Reports from the Same Industry

How can this public report be used as a reference?

Compare chapter structures, metrics, and public disclosure approaches, then check the original page for context. A peer’s disclosure is not evidence about your company; use your own data and supporting documents for actual disclosures.

Check report Build report